Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LPCN compared with NXTC: revenue, margins and what each company keeps, and the suppliers and customers both name
LPCN
Lipocine Inc.
Change
Mkt cap
Revenue
Revenue
NXTC
NextCure, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LPCN
Lipocine Inc.
vs
NXTC
NextCure, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LPCN
2 of 4 reports
Report
implied
realized
× implied
Q3 FY26
—
▲
+6.25%
—
Q2 FY26
—
▲
+0.95%
—
NXTC
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+4.47%
—
= implied
LPCN realized, solid
NXTC realized, hatched
One scale, both sides: full bar = 7%
× = |realized| ÷ implied
Source: market data
LPCN
Lipocine Inc.
Change
1.58
▲
+3.56%
· post 1.55
Mkt cap
$17.4M
Revenue
$2M
Q3 FY26
Revenue
$2M
FY25
NXTC
NextCure, Inc.
Change
5.10
▼
−0.39%
· post 5.10
Closed
Nov 6 '26
Mkt cap
$24.4M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
LPCN
Lipocine Inc.
vs
NXTC
NextCure, Inc.
1.58
▲
+3.56%
post 1.55
Price
5.10
▼
−0.39%
post 5.10
$17.4M
Mkt cap
$24.4M
Q3 FY26
$2M
Revenue
—
FY25
$2M
Revenue
—
Change
Change
LPCN
1.58
▲
+3.56%
vs
NXTC
5.10
▼
−0.39%
Closed
Nov 6 '26